Whipplewood Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7
Closed -$471 1256
2025
Q1
$471 Sell
7
-6
-46% -$404 ﹤0.01% 1131
2024
Q4
$547 Buy
+13
New +$547 ﹤0.01% 1103